In the delayed group , antiretroviral treatment was initiated at a median CD4 count of 230 ( IQR 197-249 ) cells per L. Primary clinical events were reported in 57 individuals assigned to early treatment initiation versus 77 people allocated to delayed antiretroviral treatment ( hazard ratio 073 , 95 % CI 052-103 ; p = 0074 ) .